[1]
“Respiratory syncytial virus and effect of palivizumab prophylaxis in patients with congenital heart disease ”, Ann Med Res , vol. 27, no. 9, pp. 2461–2466, May 2021, Accessed: Apr. 03, 2025. [Online]. Available: http://annalsmedres.org/index.php/aomr/article/view/925